1. Home
  2. Labeler Index
  3. Pfizer Laboratories Div Pfizer Inc
  4. 0069-0435
  5. NDC Package Code: 0069-0435-30 Cibinqo

NDC Package 0069-0435-30 Cibinqo

Abrocitinib Tablet, Film Coated Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0069-0435-30
Package Description:
30 TABLET, FILM COATED in 1 BOTTLE
Product Code:
0069-0435
Proprietary Name:
Cibinqo
Non-Proprietary Name:
Abrocitinib
Substance Name:
Abrocitinib
Usage Information:
CIBINQO is indicated for the treatment of adults with refractory, moderate-to-severe atopic dermatitis whose disease is not adequately controlled with other systemic drug products, including biologics, or when use of those therapies is inadvisable.
11-Digit NDC Billing Format:
00069043530
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
30 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 2591481 - abrocitinib 100 MG Oral Tablet
  • RxCUI: 2591487 - Cibinqo 100 MG Oral Tablet
  • RxCUI: 2591487 - abrocitinib 100 MG Oral Tablet [Cibinqo]
  • RxCUI: 2591489 - abrocitinib 200 MG Oral Tablet
  • RxCUI: 2591491 - Cibinqo 200 MG Oral Tablet
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Pfizer Laboratories Div Pfizer Inc
    Dosage Form:
    Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • ABROCITINIB 200 mg/1
    • Pharmacologic Class(es):
  • Janus Kinase Inhibitor - [EPC] (Established Pharmacologic Class)
  • Janus Kinase Inhibitors - [MoA] (Mechanism of Action)
  • P-Glycoprotein Inhibitors - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    NDA213871
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    02-24-2022
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0069-0435-30?

    The NDC Packaged Code 0069-0435-30 is assigned to a package of 30 tablet, film coated in 1 bottle of Cibinqo, a human prescription drug labeled by Pfizer Laboratories Div Pfizer Inc. The product's dosage form is tablet, film coated and is administered via oral form.This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package.

    Is NDC 0069-0435 included in the NDC Directory?

    Yes, Cibinqo with product code 0069-0435 is active and included in the NDC Directory. The product was first marketed by Pfizer Laboratories Div Pfizer Inc on February 24, 2022 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0069-0435-30?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 30.

    What is the 11-digit format for NDC 0069-0435-30?

    The 11-digit format is 00069043530. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20069-0435-305-4-200069-0435-30